Erratum to: Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines
After publication of the original article [1], the authors noticed an error within Figs. 3 and 5: Figures 3a and 5a were inadvertently missed. The full versions of Figs. 3 and 5 have been updated in the original article and can be found below. We would like to apologise for the error and for any inconvenience this may have caused.
Erratum to: Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines
Authors
Li-Hsuen Chen Wen-Lin Hsu Yen-Ju Tseng Dai-Wei Liu Ching-Feng Weng
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.